| 000 | 01655 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516193950.0 | ||
| 264 | 0 | _c20150723 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1434-9949 | ||
| 024 | 7 |
_a10.1007/s10067-014-2498-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKingsbury, Daniel J | |
| 245 | 0 | 0 |
_aSafety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years. _h[electronic resource] |
| 260 |
_bClinical rheumatology _c2014 |
||
| 300 |
_a1433-41 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBader-Meunier, Brigitte | |
| 700 | 1 | _aPatel, Gina | |
| 700 | 1 | _aArora, Vipin | |
| 700 | 1 | _aKalabic, Jasmina | |
| 700 | 1 | _aKupper, Hartmut | |
| 773 | 0 |
_tClinical rheumatology _gvol. 33 _gno. 10 _gp. 1433-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-014-2498-1 _zAvailable from publisher's website |
| 999 |
_c23507873 _d23507873 |
||